No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Drug Resistance, Neoplasm*
-
Female
-
Humans
-
Indazoles
-
Male
-
Maximum Tolerated Dose
-
Middle Aged
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / metabolism
-
Multiple Myeloma / pathology
-
Neoplasm Recurrence, Local / diagnosis
-
Neoplasm Recurrence, Local / drug therapy*
-
Prognosis
-
Pyrimidines / therapeutic use*
-
Safety
-
Salvage Therapy*
-
Sulfonamides / therapeutic use*
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
-
Vascular Endothelial Growth Factor A / metabolism
Substances
-
Indazoles
-
Pyrimidines
-
Sulfonamides
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
pazopanib